In biological terms, aging occurs as an accumulation of molecular and cellular damage over the course of one’s life
Aging leads to a gradual decline in physical and cognitive abilities and capacities
Aging individuals are at higher risk of developing diseases
These things ultimately lead to death
(WHO, 2021)
An Aging Population
The World Health Organization (WHO) has predicted that, by the year 2050, the number of people aged 60 years and older will double from its number in 2015
WHO also predicts that people aged 60 years and older will outnumber children younger than 5 years
80% of people aged 60 years and older are predicted to live in low and middle-income countries
This demographic shift presents an opportunity to meet the needs of older adults
(WHO, 2021)
Health Inequities in Aging Populations
Social Determinants of Health (SDOH) in Aging
Black adults face disparities with healthy aging as they encounter the effects of institutional and structural racism, which leads to worse health outcomes
Both social and economic factors contribute to this decline, which have again been exacerbated by structural racism
The National Institute on Aging notes that there are several SDOH that play a critical role in aging and contribute to health inequities during the aging process
These SDOH include:
Residential Segregation
Discrimination
Immigration
Social Mobility
Work and Retirement
Education
Income and Wealth
These SDOH often determine the quality of life an older adult may live as they age
Inequities in Aging for Black Adults
Black adults face disparities with healthy aging as they encounter the effects of institutional and structural racism, which leads to worse health outcomes
Both social and economic factors contribute to this decline, which have again been exacberated by structural racism
Risks of diabetes, heart disease, and stroke increase among Black adults due to hypertension and lack of diabetes prevention
A variety of explanations in the very rapid decline of the physiology of Black adults include:
Economic hardship
Shortcomings in primary disease prevention
Structural racism
Difficulties in managing chronic diseases over time
Discrimination-related stress
(Scommegna & Mather, 2021)
Relative to aging white adults, older Black adults have higher rates of disability
These disabilities often relate to and preclude older Black adults from performing the basic activities of daily living, such as bathing and dressing
The three factors that strongly contribute to these disabilities are:
Diabetes
Heart Disease
Stroke
Aging Black adults may also have less access to safe home environments and disease managing medications
COVID-19 has certainly exacerbated these historic inequities for aging Black adults
(Scommegna & Mather, 2021)
Flu and COVID-19 in Older Populations
Flu in Older Adults
Although older age groups have some of the highest seasonal influenza vaccination rates, individuals over age 65 make up 2/3 of the 200,000 flu-related hospitalizations each year, regardless of their risk for serious disease, and 90% of the approximately 36,000 annual deaths (CDC website estimates 50-70% of recent year flu hospitilizations and 70-80% of deaths are in people 65+ https://www.cdc.gov/flu/highrisk/65over.htm)
Older individuals are at higher risk for influenza-associated heart attacks, congestive heart failure, stroke, and cognitive decline
More than 1 in 7 older adults who are hospitalized for flu will experience catastrophic disability and loss of independence
It is thought that older adults have decreased protection from influenza vaccination due to age-related changes in immune system cells that produce antibodies and fight infection. This process of the immune system declining with age is called “immunosenescence”
Flu shots are also tied to a lower risk of a stroke
This flu season, CDC recommends that people 65 years and older receive a higher-dose flu vaccine or an adjuvanted flu vaccine rather than a standard dose flu vaccine because these flu vaccines are more effective in this age group
COVID-19 in Older Adults
Older unvaccinated adults are more likely to be hospitilized or die from COVID-19. People 85 years and older are the most likely to get very sick.
Per the Centers for Disease Control and Prevention, adults 65 years old and older who were fully vaccinated with an mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna) had:
94% reduction in risk of COVID-19 hospitalizations
64% decreased risk of COVID-19 hospitilization is partially vaccinated (Pfizer-BioNTech or Moderna)
Studies suggest protection from the vaccine is roughly the same as in the younger population
CDC also reccomends that everyone 12 and older who has completed the primary series recieve a COVID-19 booster dose usine one of the new bivalent (“omnicron”) booster vaccines to ensure protection against COVID-19 this fall and winter
(Ford & Savitz, 2022) (Gawthrop, 2022)(CDC)
Vaccinations for Older Populations
Updated ACIP Recommendations
ACIP recommends that adults aged ≥65 years receive one of the following influenza vaccines ○Quadrivalent high-dose inactivated influenza vaccine (HD-IIV4) ○Quadrivalent recombinant influenza vaccine (RIV4) ○Quadrivalent adjuvanted inactivated influenza vaccine (aIIV4) If none of these three vaccines is available at an opportunity for vaccine administration, then any other age-appropriate influenza vaccine should be used.
Vaccinations are Important!
According to experts, 2022 was the second straight year for an observed decline in life expectancy
The need to get people booster vaccines against COVID-19and decreasing life expectancy are two overlapping public health emergencies
COVID-19 poses a specific threat to life expectancy across Black populations
The age-adjusted mortality rate for Black Americans is 68% higher than the same measure for white Americans.
Once age-adjusted, the highest COVID-19 mortality rates for Black Americans are in Mississippi, Iowa, Nevada, New Jersey, and Michigan
(Overlapping Public Health Emergencies 2022)
Vaccinations in Older Adults
Likewise, the National Adult and Influenza Immunization Summit (NAIIS) notes that disparities in vaccinations in older adults exist
White adults aged 60 years and older had a higher rate of shingles vaccination (34.6%) than Black adults (13.6%), Hispanic adults (16.0%), and Asian American adults (26.0%)
The National Adult and Influenza Immunization Summit (NAIIS) notes that disparities in vaccinations in older adults exist
Pneumococcal vaccination is recommended for all adults 65 years and older (there are two types of pneumococcal vaccines that are needed- talk to your doctor about when you should receive each)
CDC recommends a single dose of Shingles vaccine (Zoster vaccine) for everyone 60 years and older, whether or not they have ever had shingles before
All adults should get a Tdap (Tetanus, diptheria and whooping cough) vaccine once and then a Td (tetanus, diphtheria) or Tdap booster shot every 10 years.
Adults 60 years and older with risk factors can receive a hepatitis B vaccine and those wishing to be protected may also receive this vaccine
(Overlapping Public Health Emergencies 2022)
High Flu Dose Vaccine
Among those vaccinated minority groups were 26–32% less likely to receive High-Dose VAccine (HDV), relative to white people •A study analysed many variables such as differences in education, household income, medical history, community and vaccinator characteristics did not fully explain the disparities. •The study did find that there is a racial and ethnic disparity between those who not only receive Influenza vaccinations but also those who receive HDV’s. This disparity was noted even between those who received and presumably wanted to be vaccinated against Influenza. (Mahmud, 2022) (Mahmud, 2021)
Centers for Disease Control and Prevention. (2022, February 17). Adult immunization schedule by vaccine and age group. Centers for Disease Control and Prevention. Retrieved September 23, 2022, from https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html
Ford, B. N., & Savitz, J. (2022). Depression, aging, and immunity: Implications for covid-19 vaccine immunogenicity. Immunity & Ageing, 19(1). https://doi.org/10.1186/s12979-022-00288-7
McElhaney, J. E., Verschoor, C. P., Andrew, M. K., Haynes, L., Kuchel, G. A., & Pawelec, G. (2020). The immune response to influenza in older humans: Beyond immune senescence. Immunity & Ageing, 17(1). https://doi.org/10.1186/s12979-020-00181-1